Johnson & Johnson recalls 3 million bottles of medicines, including Tylenol, Benadryl, and Motrin, because of odors traced to a chemical in pallets used to transport and store the medicines.
Germany's Federal Health Ministry demands that Johnson & Johnson deliver 6.5 million doses of its vaccine by July in order to offset a vaccine shortfall. A spokesman for the ministry says that the situation is regretful and that only 1.15 million doses of the vaccine had been administered as of last Friday.
The Marshall Islands reaches an adult population vaccination rate of nearly 75%. After completing the urban areas, the Ministry of Health and Human Services plans to distribute Moderna and Johnson & Johnson vaccines to the most remote islands of the country to vaccinate the rest of the population. The vaccines were provided as a donation by the United States.
Johnson & Johnson's single-shot COVID-19 vaccine candidate meets the standards for emergency use authorization, according to analysis from a committee within the FDA, though formal authorization will not be determined until February 26. The vaccine is 66% effective in combating the virus and can be stored in normal refrigerators.
Johnson & Johnson enters a Phase III clinical trial for its potential vaccine, becoming the fourth vaccine company backed by Operation Warp Speed to do so. The trial is expected to enroll up to 60,000 volunteers across 215 locations in the United States and other countries.
Bayer and Johnson & Johnson announce that they have reached a $775 million agreement to settle approximately 25,000 outstanding litigation cases, which claim that their drug Xarelto caused severe and sometimes fatal bleeding episodes. Bayer and Johnson & Johnson had successfully defended the safety of the drug in all six prior cases that went to trial.